This inventor holds 1 USPTO granted patent. Top assignee: Icn Pharmaceuticals, Inc.. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: **Rich B Meyer, Jr: A Pioneer in Purine Nucleotide Innovations**
Introduction
Rich B Meyer, Jr., based in Laguna Beach, California, is an accomplished inventor known for his contributions to the field of biochemistry. With a focus on purine nucleotides, Meyer has developed a patented compound that exhibits significant potential in medicinal applications.
Latest Patents
Meyer holds a patent for "6-Substituted purine 3',5'-cyclic nucleotides." This innovative patent describes novel compounds, specifically 6-alkylthio and 6-arylalkylthio purine 3',5'-cyclic nucleotides. The compounds are recognized for their various biological activities, including adenyl cyclase inhibition, tumor inhibitory properties evidenced in animal studies, interferon potentiation, antiviral activity, and an enhanced capacity to activate adenosine 3',5'-cyclic phosphate-dependent protein kinase. Notably, they exhibit superior resistance to phosphodiesterase hydrolysis compared to naturally occurring analogs. The synthesis involves a unique method of alkylation of the corresponding 6-thio nucleotide, highlighting the innovation in its development.
Career Highlights
Rich B Meyer, Jr. is associated with ICN Pharmaceuticals, Inc., an organization known for its advancements in pharmaceutical research and development. His work at ICN Pharmaceuticals underscores his dedication to enhancing therapeutic options through scientific innovations in nucleotide research.
Collaborations
Throughout his career, Meyer has collaborated with esteemed colleagues, including Dennis A Shuman and Roland K Robins. These partnerships highlight the collective effort in advancing studies and applications of purine nucleotide compounds, contributing valuable insights to the scientific community.
Conclusion
Rich B Meyer, Jr.'s contributions to the field of purine nucleotide innovation exemplify the impact of dedicated research and development in medicine. His patented work continues to inspire advancements in pharmacology and therapeutic development, reinforcing the importance of innovative thinking in addressing complex biological challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile